FULCRUM PHARMACEUTICALS
Fulcrum Pharmaceuticals applies computational chemistry, structural biology and thermodynamics to achieve accelerated design and development of drug products. Founded in 2002, Fulcrum has developed a portfolio of proprietary lead compounds targeted at inflammatory disease, osteoporosis, infectious disease and oncology. This portfolio includes small molecule inhibitors of receptors and enzymes, small molecule mimics of antibodies and receptors, and "adaptive" anti-infectives (drugs capable of overcoming resistance). Fulcrum's strategy is to out-license a portion of its pipeline, while retaining selected compounds for internal development. For more information, visit www.fulcrumpharmaceuticals.com.
FULCRUM PHARMACEUTICALS
Industry:
Health Care Medical
Founded:
2002-01-01
Address:
Henderson, Nevada, United States
Country:
United States
Website Url:
http://www.fulcrumpharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
(702) 933-0909
Email Addresses:
[email protected]
Total Funding:
8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Apache JQuery CDN EasyDNS EsayDNS Hosted EasyDNS Mail
Similar Organizations
Curzion Pharmaceuticals
Curzion Pharmaceuticals is a privately held development-stage biopharma company.
Current Employees Featured
Investors List
Fujisawa Investments for Entrepreneurship
Fujisawa Investments for Entrepreneurship investment in Venture Round - Fulcrum Pharmaceuticals
Third Point Ventures
Third Point Ventures investment in Venture Round - Fulcrum Pharmaceuticals
Official Site Inspections
http://www.fulcrumpharmaceuticals.com
Unable to get host informations!!!
More informations about "Fulcrum Pharmaceuticals"
Fulcrum Therapeutics
Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.See details»
Fulcrum Pharmaceuticals - Crunchbase Company …
Fulcrum Pharmaceuticals applies computational chemistry, structural biology and thermodynamics to achieve accelerated design and development of drug …See details»
Fulcrum Therapeutics - LinkedIn
Fulcrum Therapeutics | 12,369 followers on LinkedIn. We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high ...See details»
Fulcrum Pharmaceuticals Inc - Company Profile and News
Company profile page for Fulcrum Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Fulcrum Therapeutics - Sickle Cell Disease Association of America …
Fulcrum Therapeutics is a member of SCDAA’s SCD C.A.R.E.S. Consortium. We launched Fulcrum Therapeutics with a vision to develop small molecules to improve the lives of patients …See details»
Fulcrum Therapeutics Management - Simply Wall St
Fulcrum Therapeutics' CEO is Alex Sapir, appointed in Jul 2023, has a tenure of 1.83 years. total yearly compensation is $1.00M, comprised of 64.8% salary and 35.2% bonuses, including …See details»
Fulcrum Therapeutics - Crunchbase Company Profile
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases. The company develops a proprietary product engine that is employed to identify and validate cellular drug targets …See details»
Leadership Team - Team at Fulcrum Therapeutics - The Org
About. The leadership team at Fulcrum Therapeutics has a history of working in various human resources positions for companies in the pharmaceutical and biotech industries.See details»
Fulcrum Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Fulcrum Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:FL-233.See details»
Fulcrum Therapeutics Strengthens Leadership Team with the
Aug 19, 2024 “This is a pivotal moment, and I am thrilled to join as the company prepares to transition to a commercial-stage organization. With a strong commitment to delivering …See details»
Fulcrum Pharmaceuticals - Contacts, Employees, Board Members, …
Fulcrum Pharmaceuticals is a privately held drug design and development company. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered …See details»
Fulcrum Therapeutics - Craft
Oct 29, 2024 Fulcrum Therapeutics has 5 employees at their 1 location and $80 m in annual revenue in FY 2024. See insights on Fulcrum Therapeutics including office locations, …See details»
Fulcrum Therapeutics (FULC) Company Profile & Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of …See details»
Fulcrum Therapeutics Strengthens Leadership Team with the …
Aug 19, 2024 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs …See details»
Fulcrum Therapeutics Enters into a Collaboration and License …
May 13, 2024 ― Sanofi receives exclusive rights to commercialize losmapimod in all territories outside the U.S.; Fulcrum retains full U.S. commercialization rights ― ― Fulcrum will receive …See details»
Fulcrum's muscle degeneration drug fails but will push forward ...
Jun 25, 2021 Fulcrum picked up the molecule from GlaxoSmithKline in 2019 with commitments of up to $37.5 million in clinical and regulatory milestones. Fulcrum had believed the asset …See details»
Fulcrum Therapeutics Announces Recent Business Highlights and …
May 13, 2024 Recent Business Highlights. Fulcrum entered into a collaboration and license agreement with Sanofi (Nasdaq: SNY) for the development and commercialization of …See details»
Fulcrum Therapeutics Strengthens Leadership Team with the
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality …See details»
Fulcrum Therapeutics Announces Proposed Public Offering of
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives …See details»
Myanmar’s Military Regime is Violating its International Economic ...
Apr 9, 2025 The World Trade Organization (WTO) and International Monetary Fund (IMF) state that key reasons for promoting trade include raising living standards, ensuring full …See details»